Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients

Cassandra R Duffy; Jessica M Hart; Anna M Modest; Michele R Hacker; Toni Golen; Yunping Li; Chloe Zera; Scott A Shainker; Preeti Mehrotra; Rebecca Zash; Blair J Wylie

doi:10.1097/AOG.0000000000003984

Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients

Obstet Gynecol. 2020 Aug;136(2):229-231. doi: 10.1097/AOG.0000000000003984.

Authors

Cassandra R Duffy¹, Jessica M Hart, Anna M Modest, Michele R Hacker, Toni Golen, Yunping Li, Chloe Zera, Scott A Shainker, Preeti Mehrotra, Rebecca Zash, Blair J Wylie

Affiliation

¹ Departments of Obstetrics and Gynecology and Anesthesia, Critical Care and Pain Medicine, and the Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Abstract

Lymphopenia does not identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among asymptomatic patients admitted to an obstetrics unit or among obstetric patients under investigation for coronavirus disease 2019 (COVID-19).

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Asymptomatic Infections*
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Delivery, Obstetric
Female
Hospitalization
Humans
Lymphocyte Count
Lymphopenia / etiology*
Pandemics
Pneumonia, Viral / complications*
Pregnancy
SARS-CoV-2

Grants and funding

UL1 TR002541/TR/NCATS NIH HHS/United States